Chronic rhinosinusitis: New understanding of specific and general Quality of life scores
Volume: 54 - Issue: 4
First page: 289 - Last page: 291
A. Slovick - M. Cornet - P. Surda - P.V. Tomazic
Our goal in treating chronic rhinosinusitis (CRS) is to reduce sinonasal symptoms and improve quality of life (QoL). In patients with CRS, sinonasal symptoms have a significant impact on QoL. Various validated measures exist to quantify QoL such as the 22-item Sinonasal Outcomes Test (SNOT- 22) and MSNOT-20 Young Persons Questionnaire (MSYPQ) specific to CRS, while others measure general QoL, such as the EuroQol 5-Dimensional general health-related QoL survey (EQ5D).
Rhinology 54-4: 289-291, 2016
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.
